--- title: "DC 6330 - Campylobacter jejuni infection" diagnostic_code: "6330" body_system: "Infectious Diseases, Immune Disorders and Nutritional Deficiencies" cfr_section: "§ 4.88b" canonical: "https://veteranai.co/va-rating-schedule/infectious-and-immune/6330-campylobacter-jejuni-infection" source: "https://www.ecfr.gov/current/title-38/section-4.88b" updated: "2026-07-21T20:31:26.125465Z" --- # DC 6330 - Campylobacter jejuni infection Rated under § 4.88b. Body system: Infectious Diseases, Immune Disorders and Nutritional Deficiencies. General Rating Formula for Infectious Diseases ## Rating criteria | Rating | Criteria | | --- | --- | | 100% | For active disease | | 100% | As active disease | | 100% | As active disease | | 100% | As active disease | | 100% | As active disease | | 100% | Marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia | | 60% | With all of the symptoms listed below, plus mental symptoms and impaired bodily vigor | | 40% | With stomatitis, diarrhea, and symmetrical dermatitis | | 20% | With stomatitis, or achlorhydria, or diarrhea | | 10% | Confirmed diagnosis with nonspecific symptoms such as: decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate and irritability | | 100% | With congestive heart failure, anasarca, or Wernicke-Korsakoff syndrome | | 60% | With cardiomegaly, or; with peripheral neuropathy with footdrop or atrophy of thigh or calf muscles | | 30% | With peripheral neuropathy with absent knee or ankle jerks and loss of sensation, or; with symptoms such as weakness, fatigue, anorexia, dizziness, heaviness and stiffness of legs, headache or sleep disturbance | | 100% | Marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia | | 60% | With all of the symptoms listed below, plus mental symptoms and impaired bodily vigor | | 40% | With stomatitis, diarrhea, and symmetrical dermatitis | | 20% | With stomatitis, or achlorhydria, or diarrhea | | 10% | Confirmed diagnosis with nonspecific symptoms such as: decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate and irritability | | 100% | As active disease | | 0% | As acute or asymptomatic chronic disease | | 100% | Not to be combined with ratings under DC 7809 Acute, with frequent exacerbations, producing severe impairment of health | | 60% | Exacerbations lasting a week or more, 2 or 3 times per year | | 10% | Exacerbations once or twice a year or symptomatic during the past 2 years | | 100% | AIDS with recurrent opportunistic infections (see Note 3) or with secondary diseases afflicting multiple body systems; HIV-related illness with debility and progressive weight loss | | 60% | Refractory constitutional symptoms, diarrhea, and pathological weight loss; or minimum rating following development of AIDS-related opportunistic infection or neoplasm | | 30% | Recurrent constitutional symptoms, intermittent diarrhea, and use of approved medication(s); or minimum rating with T4 cell count less than 200 | | 10% | Following development of HIV-related constitutional symptoms; T4 cell count between 200 and 500; use of approved medication(s); or with evidence of depression or memory loss with employment limitations | | 0% | Asymptomatic, following initial diagnosis of HIV infection, with or without lymphadenopathy or decreased T4 cell count | | 100% | Which are nearly constant and so severe as to restrict routine daily activities almost completely and which may occasionally preclude self-care | | 60% | Which are nearly constant and restrict routine daily activities to less than 50 percent of the pre-illness level; or which wax and wane, resulting in periods of incapacitation of at least six weeks total duration per year | | 40% | Which are nearly constant and restrict routine daily activities from 50 to 75 percent of the pre-illness level; or which wax and wane, resulting in periods of incapacitation of at least four but less than six weeks total duration per year | | 20% | Which are nearly constant and restrict routine daily activities by less than 25 percent of the pre-illness level; or which wax and wane, resulting in periods of incapacitation of at least two but less than four weeks total duration per year | | 10% | Which wax and wane but result in periods of incapacitation of at least one but less than two weeks total duration per year; or symptoms controlled by continuous medication | ## Notes - Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, Guillain-Barre syndrome, reactive arthritis, or uveitis. # Campylobacter jejuni Infection — VA Disability Rating (Diagnostic Code 6330) **Body System:** Infectious Diseases, Immune Disorders and Nutritional Deficiencies **Regulation:** 38 CFR § 4.88b **Rated Under:** General Rating Formula for Infectious Diseases --- ## What Is Campylobacter jejuni Infection? Campylobacter jejuni is a bacterial infection. Under the VA rating schedule, it appears in the section covering Infectious Diseases, Immune Disorders and Nutritional Deficiencies and is evaluated using the General Rating Formula for Infectious Diseases (Diagnostic Code 6330). An important part of how the VA handles this condition involves the residual effects an infection can leave behind. According to the rating note: > **Note:** Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, Guillain-Barré syndrome, reactive arthritis, or uveitis. This means that lingering conditions that develop as a result of the infection may be evaluated separately under the body system that applies to them. --- ## Available Rating Levels The rating schedule ties the level of evaluation to whether the disease is active and to the specific symptoms present. Key evaluation points listed in the data include: - **100%** — For active disease. - **0%** — As acute or asymptomatic chronic disease. Because the entry is rated under the General Rating Formula for Infectious Diseases, the material provided also lists criteria drawn from that broader framework across a range of percentages (0%, 10%, 20%, 30%, 40%, 60%, and 100%), tied to varying combinations of symptoms and their impact. Examples of the described criteria include: - **10%** — Confirmed diagnosis with nonspecific symptoms such as decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate, and irritability; or symptoms that wax and wane with periods of incapacitation of at least one but less than two weeks total per year, or symptoms controlled by continuous medication. - **20%** — With stomatitis, or achlorhydria, or diarrhea; or symptoms that restrict routine daily activities by less than 25 percent of the pre-illness level, or periods of incapacitation of at least two but less than four weeks total per year. - **30%** — Peripheral neuropathy with absent knee or ankle jerks and loss of sensation; or symptoms such as weakness, fatigue, anorexia, dizziness, heaviness and stiffness of legs, headache, or sleep disturbance. - **40%** — With stomatitis, diarrhea, and symmetrical dermatitis; or symptoms that restrict routine daily activities from 50 to 75 percent of the pre-illness level, or periods of incapacitation of at least four but less than six weeks total per year. - **60%** — Combinations of the lower-level symptoms plus mental symptoms and impaired bodily vigor; cardiomegaly, or peripheral neuropathy with footdrop or atrophy of thigh or calf muscles; exacerbations lasting a week or more, two or three times per year; or symptoms restricting routine daily activities to less than 50 percent of the pre-illness level, or periods of incapacitation of at least six weeks total per year. - **100%** — Active disease; marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia; congestive heart failure, anasarca, or Wernicke-Korsakoff syndrome; nearly constant symptoms so severe as to restrict routine daily activities almost completely and which may occasionally preclude self-care. --- ## What the VA Looks For When evaluating this condition, the VA looks at: - **Whether the disease is active** — active disease is a 100% criterion, while acute or asymptomatic chronic disease is a 0% criterion. - **The presence and combination of specific symptoms** — such as stomatitis, diarrhea, achlorhydria, dermatitis, and neurological or mental symptoms. - **The degree to which symptoms limit routine daily activities** and the total duration of any incapacitating periods across the year. - **Whether symptoms are controlled by continuous medication.** - **Residual disabilities of the infection** — conditions such as Guillain-Barré syndrome, reactive arthritis, or uveitis are rated under the appropriate body system that applies to them. --- *This information summarizes the rating criteria for Diagnostic Code 6330 as provided. It is a general overview of how the condition is described in the rating schedule and is not legal advice or a prediction of any individual outcome.* Source: https://www.ecfr.gov/current/title-38/section-4.88b